Revista de Gastroenterología del Perú - Volumen 17, Suplemento Nº1 1997

 

BIBLIOGRAFÍA

 

1.- ISAACSON PG. Gastrointestinal lymphoma. Hum Pathol 25:1020-1029, 1994.

2.- GALETTI G, BARBARA L. Gastric Lymphoma:Diff icult to diagnose, difficult to staging. Endoscopy 25:528-530,1993 (Edit).

3.- ISAACSON PG. Recent developments in our understanding of gastric lymphomas. Am J Surg Pathol 20:S1 -S7, 1996 (suppll).

4.- HAYES J, DUNN E. Has the incidence of primary gastric lymphoma increased ? Cancer 63:2073-2076,1989.

5, SEVERSON RK, DAVIS S. Increasing incidence of

primarygastric lymphoma. Cancer 66:1283-1287,1990.

6.- PARSONNET J, HANSEN S, RODRIGUEZ L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J 330: 1267-1271, 1994

7. VILLAR HV, WONG R, PAZ B, et al. Immunophenotyping in the management of gastric lymphoma. Am J Surg 161:171-175, 1991

8.- ISAACSON PG, NORTON AJ. Mucosa-associated lymphoid tissue (MALT) and the MALT lymphoma concept. In:ISAACSON PG, NORTON AJ,eds. Extranodal lymphomas, New York:ChurchillLivingstone, 1994:5-14

9.- GENTA RM, HAMMER HW, GRAHAM DY. Gastric lymphoid follicules in Helicobacter pylori infection:

Frecuency, distribution, and response to triple therapy.Hum Pathol 24:577-583, 1993

10.WESTON AP, CHERIAN R, HORVAT RT, et al. Mucosaassociated lymphoid tissue (MALT) in Barrett's esophagus: Prospective evaluation and association with Gastric MALT, MALT lymphoma and Helicobacter pylori. Am J Gastroenterol 92:800-804,1997

11.WOTHERSPOON AC, ORTIZ-HIDALGO C, FALZON MR, et al. Helicobacter pylori-associated gastritis and p6maryB-celigastriclymphoma. Lancet338: 1175-1176,1991.

12. ISAACSON PG. Gastrointestinal lymphoma. Hum Pathol 25: 1020-1029, 1994.

13. DOGLIANI C, WOTHERSPOON A, MOSHINI A, et al. High incidence of primary gastric lymphoma in Northeastern Italy. Lancet 339: 834-835, 1992.

14. ROGGERO E, ZUCCA E, CAVALLI F. Gastric mucosa-associated lymphoid tissue lymphoma: More than a fascinating model J Natl Cancer Inst 89: 1328-1330, 1997.

15. HUSSELL T, ISAACSON PG, GRABTREE JE. The response of cells from low-graded B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicoabcter pylori. Lancet 342: 371-574,1993.

16. HUSSELL T, ISAACSON PG, GRABTREE JE. Helicobacter pylori specific tumour infiltrating T cells provide contact dependent help for the growth of malignant B cells in low grade gastric lymphoma of mucosa associated lymphoid tissue. J Pathol 178: 122-127, 1996.

17.- A clinical evaluation of the International Lymphoma Study Group classification of Non-hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89: 3909-3918,1997.

18.WOTHERSPOON AC, DOGLIANI C, DISS TC. Regression of primary low-graded B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after erradication of Helicobacter pylori. Lancet 342:575577, 1993.

19. MONTALBAN C, MANZANAL A, BOIXEDA D. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori erradication. Lancet 345:798-799,1995.

20. ROGGERO E, ZUCCA E, PINOTTI G. Erradication of Helicobacterpylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med. 122:767-769,1995.

21 WEBER DM, DIMOPOULOS MA, ANANDU DP. Regression of gastric lymphomaof mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 107: 1835-1838, 1994.

22.BAYERDbRFFER E, NEUBAUER A, RUDOLPH B. Regression of primary gastric lymphoma of mucosa associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345: 1591-1594, 1995.

23 NEUBAUER A, THIEDE CH, MORGNER A, et al. Cure of Helicobacterpylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89: 1350-1355, 1997.

24.- PARSONNET J. Gastric Lymphoma: Diagnosis and treatment in 1996. Fennerty MB, Rex DK dir. Annual Postgraduate Course, ACG, 1996; 147-153

25. CAMMAROTA G, MONTALTO M, TURSI A et al. Helicobacter pylori reinfection and rapid relapse of lowgrade B-cell gastric lymphoma. Lancet 345:192,1995

26.- BEWAYED F, HALPHEN M, NAJJAR T, et al. Treatment of alpha chain disease. Results of a prospective study in 21 Tunasian patients by the Tunisian-French Intestinal Lymphoma study Group. Cancer 63:1251-1256,1989.

27. ISAACSON PG. Is gastric lymphoma an infectious disease ?. Hum Pathol 24: 569-570, 1993

28. Nagashima R, Takeda H, Maeda K, et al. Regression of duodenal mucosa-associated linphoid tissue lymphoma after erradication of Helicobacter pylori. Gastroenterology 111: 1674-1678,1996.

29. NAJEM AZ, PORCARO JL, RUSH BF. Primary non Hodgkin's lymphomaof theduodenum. Cancer54: 895-898,1984.

30. MADSEN JE, VETVIK K, AASE S. Helicobacter pylori and chronic inflammation of theduodenum andstomach in duodenal ulcer patients treated with ranitidine, misoprostol, or an acid neutralizing agent. Scand J Gastroenterol 26:465-470,1991.

31. PARKIN DM, LAARA E, MUIR CS. Estimates of the worldwide frecuency of sixteen mayorcancers in 1980. Int J Cancer 41: 184-197,1988

32. PARSONNET J, FRIEDMAN GD, VANDERTEEN DP. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131, 1991

33. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 22: 89-104, 1993.

34. GALVEZ-BRANDON (Ed). Un programa de registro de incidencia de cáncer en Lima metropolitana. Instituto Nacional de Enfermedades Neoplásicas. Lima,1973.

35. OLIVARES L. Cáncer incidence in Perú. In Aoki, et al (Eds). Cancer prevention in developing countries. University Press. Nagoya,1982.

36. FORMAN D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 215: 48-51, 1996(Suppl)

37. KUIPERS EJ, UYTERLINDE AM, PENA AS. Long-term sequelae of Helicobacter pylori gastritis. Lancet 345: 1525-1528,1995.

38. The Eurogast Study Group. An International association between Helicobacter pylori infection and gastric cancer. Lancet 341: 1359-1362, 1993

39. Sesión Seminario de la Reunión sobre:"Infección por Hp en el mundo en desarrollo". SACK RB, GYR K, LEON-BAROA R. Diagnóstico 35:42-45,1996.

40. ENDO S, OHKUSA T, SAITO Y. Detection of Helicobacter pylori infection in early stage gastric cancer. A comparison between intestinal and diffuse type gastric adenocarcinoma. Cancer 75: 2203-2208, 1995.

41. RECAVARREN-ARCE S, LEON-BAROA R, COK J, et al. Helicobacterpylori and progressive gastric pathology that predispose to gastric cancer. ScandJ Gastroenterol 26:51-57,1991 (Suppl)

42. DIXON MF, ECTORS NL. CAncer Gistrico. Current opinion in Gastroenterology 11: 38-41, 1995(suppl).

43. KOKKOLA A, VALLE J, HAAPIAINEN R, et al. Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol 31: 643-647, 1996

44. NOMURA A, STEMMERMANN GN, CHYOU PH. Helicobacter pylori infection and gastric carcinoma among japanese american in Hawai. N Engl J Med 325: 1132-1136, 1991.

45. SIPONNE P, RIIHELA M, HYVARINEN H. Chronic nonatrophic (superficial) gastritis increase the risk of gastric carcinoma:a case-control study. Scand J Gastroenterol 29:336-340,1994

46. MC COLL KEL, EL-OMAR E, GILLEN D. The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer. Seminars in Gastrointestinal Disease 8: 142-155,1997.

47.CORREA P, FOX J, FONTHAM E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 66:2569-2574,1990.

48. The Gastrointestinal Physiology Working Group. Helicobacter pylori and gastritis in peruvian patients: Relationship to socioeconomic level, age, and sex. Am J Gastroenterol 85: 819-823,1990.

49. LEON-BAROA R, RECAVARREN-ARCE S, BERENDSONR, etal. HelicobacterpyloriycAncer g6strico. Rev Gastroenterol Perú 15: S23-S27, 1995.

50. KLEIN PD. Gastrointestinal Physiology Working Group of Cayetano HerediaandtheJohns Hopkins Universities. Graham DY, Gaillou A, Opekun AR, et al. Water source as risk factor for Helicobacterpylori infection in peruvian children. Lancet 337: 1503-1506,1991.

51. HULTEN K, HAN SW, ENROTH H. Helicobacter pylori in the Drinking water in Per6. Gastroenterology 110: 1031-1035, 1996.

52. CORREA P. A human model of gastric carcinogenesis. Cancer Res 44: 3554-3560, 1988.

53. FORMAN D. Helicobacter pylori infection: A novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst 83:1702-1703,1991.

54. LEON-BAROA R, RECAVARREN-ARCE S, GILMAN RH. Can erradication of Helicobacter pylori prevent gastric cancer ? Drugs 46: 341-346,1993.

55. STEMMERMANN GN. Intestinal metaplasia of the stomach. Cancer 74:556-564, 1994.

56. TALLEY NJ, ZINSMEISTER AR, WEAVER A, et al. Gastric adenocarcinorna and Helicobacter pylori infection. J Natl Cancer Inst 83: 1734-1739,1991.

57. TYTGAT GNJ. Long-term consequences of Helicobacterpylori erradication. ScandJ Gastroenterol 205:38-44,1994 (Suppl).

58. MATSUI T, MATSUKAWA Y, SAKAI T, et al. Effect of ammonia on cell-cycle progression of human gastric cancer cell, Eur-J-Gastroenterol-Hepatol 7:S7-S81, 1995(Suppl).

59. SOBALA GM, O'CONNOR HJ, DUVAR E, et al. Histological consequences of bile reflux on the gastric mucosa with special reference to intestinal metaplasia. J Clin Pathol 46: 235-240, 1993.

60. KUIPERS EJ, UYTERLINDE AM, PENA AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid supperssive therapy: Implications for longterm safety. Am J Gastroenterol 90:1401-1406, 1995

61. YASUNAGA Y, SHINOMURA Y, KANAYAMA S, et al. Improved fold width and increased acid secretion after erradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 35:1571-1574, 1994.

62. RUIZ B, ROOD JC, FONTHAM ETH, et al. Vitamin C concentration in gastric juice before and after antiHelicobacter pylori treatment. Am J Gastroenterol 89: 533-539, 1994.

67. JABLONOSWKI H, ENGELS KJ, KRAEMER N, et al. Eff ectsof Helicobacter pylori on histamine and carbachol stimulated acid secretion by human parietal cells. Gut 35: 755-757, 1994.

68. CAVE DR, VARGAS M. Effect of Helicobacter pylori protein on acid secretion by parietal cells. Lancet 2: 187-189, 1989.

69. NOACH LA, BOSMA NB, JANSEN J, et al. Mucosal tumor necrosis factor-a, interleukin-1 b, and interleukin8 production inpatients with Helicobacterpylori infection. Scand J Gastroenterol 29:425-429,1994.

70. WALLACE JL, CUCALA M, MUGRIDGE K, et al. Secretagogue-specific effects of interleukin-1 ongastritc acid secretion. Am J Physiol 261: G559-G564,1991.

71. SOBALAGM, GRABTREEJE, DIXON MF, etal. Acute Helicobacter pylori infection: Clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 32:1415-1418,1991.

72. EL-OMAR E, WIRZ A, MC COLL KEL. Divergent effects of H. pylori on acid secretion. Gut 37: A6, 1995 (suppl,abst).

73. WARING AJ, DRAKE IM, SCHORAH CJ, etal. Ascorbic acid and total Vitamin C concentrations in plasma, gastric juice,and gastrointestinal mucosa:Effects of gastritis and oral supplementation. Gut 38:171176,1996.

74. DRAKE IM, DAVIES MJ, MAPSATONE NP, et al. Ascorbic acid protect againts human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 17: 559-562,1996.

75. ROKKAS T, PAPATHEODOROU G, KARAMERIS A, et al. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of erradication. Dig Dis Sci 40:615-621,1995.

76. CORREA P. FOX J, FONTHAM E, et al. Is gastric carcinoma an infectious disease ? N EngI J Med 325: 1170-1171,1991.

77. HOLCOMBEC. Helicobacterpylori:TheAfrican enigma. Gut 33: 429-431, 1992. 

 

Atrás